Comparision between immunomodulator drug (rituximab) and immunosuppressant drug (steroids) versus only steroids in blistering disorder of ski
Not Applicable
- Conditions
- Health Condition 1: L100- Pemphigus vulgaris
- Registration Number
- CTRI/2019/01/017157
- Lead Sponsor
- GMERS Medical College and Hospital Sola
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients of above 18 years and of any gender , who willing to sign written informed consent.
Exclusion Criteria
Any patient with active bacterial, viral, invasive fungal infections.
HIV reactive patients.
Any haematological dyscrasia/ Bleeding tendency.
Patients with history of any severe drug reaction in past.
Patients with metabolic disturbances, cardiac disorders.
Pregnancy and lactation.
Patients or relatives â?? not willing to sign written informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method we will evaluate for cumulative dose of systemic steroids & time require to reach minimum dose (10 mg prednisolone daily) in each patients after 4 monthsTimepoint: Patients will be followed up: Weekly for 1 month Fortnightly for 4 months
- Secondary Outcome Measures
Name Time Method study any side effects in both groups.Timepoint: From initiation of treatment to 4 months